Our Research

Cardiac Physiology & Transplantation

AR - Cardiac Physiology & Transplantation cropped

The Cardiac Physiology and Transplantation Division, headed by Professor Michael Feneley, is made up of four groups that take diverse and complementary approaches to heart disease, heart failure and transplantation.

Professor Michael Feneley also leads the Cardiovascular Mechanics Laboratory, which  investigates the contractile properties of the heart and how these properties change in different disease states.

The Heart Transplantation Laboratory, headed by Professor Peter Macdonald, is focused on the preservation of donor organs and clinical trials of new therapies to improve patient outcomes after heart transplantation. Prof Macdonald is also investigating new treatments for pulmonary arterial hypertension.

The Pulmonary Hypertension Laboratory is run by Professor Anne Keogh, who is a Senior Heart Transplant Cardiologist at St Vincent’s Hospital. Prof Keogh’s research program at the Victor Chang Institute focuses on pulmonary arterial hypertension, heart transplantation, immunosuppression and left heart failure clinical trials.

The Vascular-Ventricular Interactions Laboratory, headed by Professor Michael O’Rourke, has been focusing on how arterial stiffening adversely effects left ventricular load and function upstream and small vessel structure and function downstream.


Find out more about our labs, people and available position...

Developmental & Stem Cell Biology

AR - Developmental & stem Cell BiologyThe Developmental and Stem Cell Biology Division, headed by Professor Richard Harvey, aims to understand the molecular basis of inherited birth defects, the identification and characterisation of adult cardiac stem cells and the genetic pathways controlling cardiac regeneration.

The groups in this division use both mouse and zebrafish as model genetic systems as well as collaborating with clinicians to analyse inherited birth defects in humans. The division consists of three laboratories; The heart development and adult cardiac stem cell laboratory headed by Professor Richard Harvey, the Embryology laboratory headed by Professor Sally Dunwoodie and the Cardiac Regeneration Laboratory headed by Dr Kazu Kikuchi.

Find out more about our labs, people and available position...

Molecular Cardiology & Biophysics

AR Molecular Cardiology & BiophysicsThe Molecular Cardiology and Biophysics Division, headed by Professor Robert Graham, aims to understand both the molecular signaling pathways that operate within the heart and the molecular basis of inherited genetic heart diseases including cardiomyopathies and arrhythmia syndromes.

The division consists of five laboratories including the Receptor Signaling Laboratory headed by Professor Robert Graham, the Inherited Heart Diseases Laboratory headed by Professor Diane Fatkin, the Mechanobiology Laboratory headed by Professor Boris Martinac, the Mark Cowley Lidwill Cardiac Electrophysiology Laboratory headed by Professor Jamie Vandenberg and the Computational Cardiology Laboratory headed by Dr Adam Hill. Based in Western Australia, Professor Livia Hool is the head of the Cardiovascular Electrophysiology Laboratory.

Find out more about our labs, people and available position...

Vascular Biology

AR - Vascular BiologyThe aim of the Vascular Biology Program is to better understand the process called atherosclerosis, or the hardening of blood vessels.  Atherosclerosis is the single biggest cause of heart attacks and stroke, and thus death, in Australia. This program studies the contribution of oxidative processes to atherosclerosis, and how the disease can be inhibited.  There is currently one laboratory in the Vascular Biology Division, headed by Professor Roland Stocker, who joined the Institute at the end of 2012.

Find out more about our labs, people and available position...

Molecular, Structural & Comp. Biology

AR - Molecular Structural & Computational BiologyThe Molecular, Structural and Computational Biology Division seeks to understand the function of the heart in health and disease at the molecular level, and to understand the mechanisms of gene regulation.

There are three groups in this division, headed by Dr Daniela Stock, Associate Professor Catherine Suter and Dr Joshua Ho.  Understanding the molecular mechanisms of proteins that are central to the development, maintenance and proper functioning of our hearts, as well as the processes of gene expression, is crucial for diagnosis, drug design and treatment of disease.

The Structural Biology Laboratory is headed by Dr Daniela Stock, the Epigenetics Laboratory is headed by Associate Professor Catherine Suter, and the Bioinformatics and Systems Medicine Laboratory is headed by Dr Joshua Ho alongside Group Leader, Dr Eleni Giannoulatou.  After seven years at the Victor Chang Institute Dr Lawrence Lee is continuing his pioneering research into bionanotechnology at UNSW. He is now a valued member of our Honorary Faculty.


Find out more about our labs, people and available position...


Patch clamp electrophysiology Ion channels are the molecular building blocks of electrical signaling in the heart

Find out more

Congenital heart disease (CHD) Is a result of structural abnormalities that occur during the development of the heart

Find out more

Hypoxystation and metabolic reprogramming ... how cells change their metabolism to form new blood vessels in low oxygen environments.

Find out more

job vacancies

PhD Project Opportunity Investigating effects of gene-environment interaction in birth defects

Find out more

PhD Project Opportunity Modeling of cardiac arrhythmias

Find out more

PhD Project Opportunity Evaluation of gene variants derived from next-generation sequencing in families with inherited...

Find out more


Do you have a question but cannot find the answer?

ask the institute

Privacy Policy

1. Our privacy commitment

The Victor Chang Cardiac Research Institute respects your privacy.

We collect, store and use your personal information to help us fight heart disease. This Privacy Policy explains how we handle the personal information we collect relating to our fundraising activities – this includes marketing, events, our website, and health promotion services such as the Health Check Booth.

2. What types of personal information we collect

Personal information means information that identifies you or that could reasonably be used to identify you. The types of personal information we collect may include your name, gender, contact information, email address, credit/debit card information and if you consent to take part in our activities and events, health promotion services or to receive marketing materials from us.

3. Health information and other sensitive information

We do not collect health information or other types of sensitive information as part of our general fundraising activities or through our general web-site.

4. Using unsolicited information

Unsolicited information is information that is given to us that we haven’t asked for, from you or anyone else. If we receive this type of information, we will check whether this information is reasonably necessary for what we do. If it is, we’ll handle this information in the same way we do all personal information under privacy laws. If we don’t need it we’ll destroy or de-identify it.

5. How we collect your personal information

Where possible, we will collect your personal information directly from you. This may be in person (e.g. when you attend an event), on the telephone, or on-line.

We only collect information by lawful and fair means.

We may also obtain personal information from third parties or publicly available sources. In this case, we will take reasonable steps to contact you and ensure that you are aware of the circumstances surrounding the collection and purposes for which we collected your personal information.

6. Why we collect your personal information

We may collect your personal information for a number of purposes, including:

  • Marketing: to communicate with you about donations, our activities and fundraising events.
  • Health promotion: to provide you with services and information related to cardiovascular disease and its risk factors and research-related events and seminars.
  • Other activities: communicating with you to verify your identity, to improve and evaluate our programs and services, and to comply with relevant laws.

7. What happens if you don’t provide your information?

If you do not provide some or all of the personal information requested, we may not be able to offer you services, process your donations, or provide you with information about our events and activities.

8. Using a pseudonym or engaging with us anonymously

Anonymous donations may be made to the Victor Chang Cardiac Research Institute at any time by contacting us directly. Please note that we are unable to provide anonymous donors with receipts.

If you want to make a general enquiry or browse our web-site you can do so anonymously.

9. Website usage information and cookies

We do not use ‘cookies’ or any other methods to record information that is personally identifiable such as a visitor’s contact details, IP address, or domain name. We do use ‘cookies’ to anonymously track visits to our web pages and the documents that are downloaded in order to compile statistical information. This provides us with information about which pages are popular. If you prefer for ‘cookies’ not to be used, you can set your browser to disable them.

10. When we disclose your personal information

We may need to disclose your personal information to our agents in order to carry out our fundraising activities. This may include agencies who perform services on our behalf, such as mailing houses, printers, information technology services providers, archiving services, database services and telemarketing agencies. These services will always be provided under strict confidentiality agreements.

In rare cases, we may be required by law to disclose your information to a government or law enforcement agency (for example to investigate an allegation of credit card fraud).

11. Security of our information

We take all reasonable steps to protect the personal information we hold from misuse, interference and loss, and from unauthorised access. Electronic information is stored on secure servers that are protected in controlled facilities.

We do not use data hosting facilities or third party service providers that store information overseas.

Hard copy information is generally stored in our offices, which are secured to prevent entry by unauthorised people. Any personal information not actively being used is archived, usually for 7 years, with a third party provider of secure archiving services. Where personal information is stored with a third party, we have strict agreements in place that require those third parties to maintain the security of the information.

12. Security of direct debit and credit card information

We use a third-party financial institution to process our credit card transactions. It receives the credit card number and other personal information of our donors only to verify credit card numbers and to process credit card transactions in a secure environment. Where your financial information is stored on our servers, access to this information is restricted to our authorised staff only.

13. Accessing or changing your personal information

We take reasonable steps to make sure that the information we collect and use is accurate, up-to-date and complete. You may contact our Fund Development Officer at any time if you wish to:

  • change or correct your personal information (for example address or telephone number)
  • cancel some or all of the communications that we provide (we include opt-out mechanisms on the majority of our communications)
  • request access to the information that we hold about you
  • request further information about our privacy policy.

14. Questions and complaints

If you have any questions, concerns or complaints about the way in which we have handled your personal information, please contact our Fund Development Officer.

Once we receive a complaint, we will respond to you as soon as possible and will let you know if we need any further information from you. We will notify you of our decision within 30 days, however, if we are unable to do so, we will let you know the reason for the delay and the expected timeframe for resolving the complaint.

You may also lodge a complaint with the Office of Australian Information Commissioner, for more information visit www.oaic.gov.au.

15. How to contact the Fund Development Officer




Victor Chang Cardiac Research Institute
PO Box 699
Darlinghurst NSW 2010

Telephone 1300 842 867

For a copy of our full privacy policy, please click here.

Updated: March 2014